A new clinical trial is testing whether targeting treatments to a genetic anomaly can lead to better treatments for prostate cancer.
Xofigo, a newly approved treatment for advanced prostate cancer, delivers a powerful punch of radiation directly to tumor cells that have invaded the bone.
New laser therapy among treatment options for lymphedema
Dietitians offer strategies for controlling weight after cancer treatment
Bone health may be of particular concern for cancer survivors. People with breast or prostate cancer who undergo treatments that block specific hormones may be at higher risk of thinning bones. Also, certain chemotherapy drugs used to treat these or other cancers may induce ovarian failure in younger women, causing bones to thin as a result of early menopause and estrogen deprivation. In addition, steroids may also accelerate bone loss in both men and women.